FletcherJ.C., “Moral Problems and Ethical Issues in Prospective Gene Therapy,”Virginia Law Review69 (1983): 515–546.
2.
Fletcher's final book, which he completed after the death of his long time colleague Dorothy Wertz, continued this line of inquiry on a global scale, see WertzD. and FletcherJ.C., Genetics and Ethics in Global Perspective (New York: Kluwer, 2004).
3.
See e.g., FletcherJ. C. and WertzD., “Ethics, Law and Medical Genetics: After the Human Genome is Mapped,”Emory Law Journal39 (1990): 747–810; FletcherJ. C., “The Bioethics Movement and Hospital Ethics Committees,”Maryland Law Review50 (1991): 859–891; FletcherJ. C., Book Review Essay: “Conflicts of Interest in Clinical Practice and Research”, SpeceR. G.Jr.ShimmD. S., and BuchananA. E., eds, 18Journal of Legal Medicine387 (1997).
4.
FletcherJ.C., “Moral Problems and Ethical Issues in Prospective Gene Therapy,”Virginia Law Review69 (1983): 515–546, at 515, note 5.
5.
FletcherJ. C., Book Review, “Standard of Care: The Law of American Bioethics, by George Annas,”Journal of Contemporary Health Law and Policy10 (1994): 589–603.
6.
FletcherJ.C., “Bioethics in a Legal Forum: Confessions of an Expert Witness,”Journal of Medicine and Philosophy22 (1997): 297–324, at 316.
7.
Doing bad in the name of good? The Tuskegee Syphilis Study and its legacy [videorecording], Claude Moore Health Sciences Library, University of Virginia (1994).
See FletcherJ. C., “A Case Study in Historical Relativism” in Tuskegee's Truths, ReverbyS., ed., (Chapel Hill: University of North Carolina Press, 2000) 276–298.